Fig. 3.
Fig. 3. Videomicrographs showing inhibition of PAF-induced SS RBC adhesion in the ex vivo mesocecum vasculature in the presence of MoAb 7E3 F(ab′)2. / (A-C) Ex vivo preparation treated with OC125 F(ab′)2(control antibody) and PAF: (A) clear venular lumen during artificial perfusion with Ringer-albumin; (B) the passage of SS RBCs after a bolus infusion is accompanied by adhesion of these cells in venules; (C) after the passage of the bolus, a large number of SS RBC are seen adhering to the vessel wall during perfusion with Ringer-albumin. (D-F) Ex vivo preparation treated with MoAb 7E3 and PAF: (D) venules during the artificial perfusion; (E) rapid flow of SS RBCs in the vessels after a bolus infusion; (F) after the passage of the bolus, only few SS RBC adhere to the vessel wall. Visit the article on the website (www.bloodjournal.org) to download the video.

Videomicrographs showing inhibition of PAF-induced SS RBC adhesion in the ex vivo mesocecum vasculature in the presence of MoAb 7E3 F(ab′)2.

(A-C) Ex vivo preparation treated with OC125 F(ab′)2(control antibody) and PAF: (A) clear venular lumen during artificial perfusion with Ringer-albumin; (B) the passage of SS RBCs after a bolus infusion is accompanied by adhesion of these cells in venules; (C) after the passage of the bolus, a large number of SS RBC are seen adhering to the vessel wall during perfusion with Ringer-albumin. (D-F) Ex vivo preparation treated with MoAb 7E3 and PAF: (D) venules during the artificial perfusion; (E) rapid flow of SS RBCs in the vessels after a bolus infusion; (F) after the passage of the bolus, only few SS RBC adhere to the vessel wall. Visit the article on the website (www.bloodjournal.org) to download the video.

Close Modal

or Create an Account

Close Modal
Close Modal